TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 3 | 2 | 4 | 45 | 29 | 83 | 28 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 50 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/1/10 18:06 | 11/30/10 | ANAC | Anacor Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Leschly Mark | NY | DT | P.d | 12,000 | 5.00 | 3 | 2,400 | 75 | 5,621 | I | -2 | 3 | 4 | 2 | 56 | 14 | -2 | ||||||||
2/15/05 13:41 | 2/11/05 | TRCA | Tercica Inc | DE | Health | Drug | Pharmaceutical Preparations | Leschly Mark | NY | DT | P | 2,600 | 8.00 | 0 | 325 | 12 | 2,992 | I | |||||||||||||||
6/29/04 12:57 | 6/25/04 | SNMX | Senomyx Inc | DE | Health | Biolab | Commercial Physical & Biologi | Leschly Mark | NY | D | P.d | 1,500 | 6.00 | 3 | 250 | 10 | 2,689 | I | -2 | 3 | 0 | 6 | 34 | 44 | 168 | ||||||||
3/24/04 19:37 | 3/22/04 | TRCA | Tercica Inc | DE | Health | Drug | Pharmaceutical Preparations | Leschly Mark | NY | DT | P.d | 6,003 | 9.00 | 0 | 667 | 33 | 2,667 | I | |||||||||||||||
1/13/04 21:45 | 1/9/04 | NTMD | Nitromed Inc | DE | Health | Drug | Pharmaceutical Preparations | Leschly Mark | NY | DT | P | 2,400 | 8.00 | 0 | 300 | 6 | 5,445 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |